Image Results

TARCEVA Pages on BioPortfolio:

Biotechnology News TARCEVA Search
SmartBrief: Oct 23 2009 5:36AM Matching: tarceva, Find similar documents .... Net revenues from the unconsolidated joint business for Tarceva of $51 million
...
http://www.bioportfolio.co.uk/TARCEVA-news.htm...

Combining Avastin and Tarceva as a synergistic approach to cancer?
The development of Avastin (bevacizumab) and Tarceva are promising to improve this situation as well as offering hope to other patients with diverse cancers
...
http://www.bioportfolio.com/LeadDiscovery/PubMed-030511.html...

Biotechnology News Osi Search
UPDATE 1-OSI Pharma posts higher Tarceva global sales in Q3 ... 30, Tarceva's global net sales were about $301 million, of which U.S. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - Tarceva
Tarceva - BioPortfolio - Indepth. ... Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer
...
http://www.bioportfolio.com/indepth/Tarceva.html...

BioPortfolio.com - BioWeb OMNITROPE SOMATROPIN RECOMBINANT isrupt ...
Home Contact Us Site Index Search [ Products -- Nutropin ] Products Home ONCOLOGY Avastin Herceptin Rituxan Tarceva IMMUNOLOGY Raptiva Xolair VASCULAR
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...

BioPortfolio - TARCEVA - Profile
Imaging Economics: Oct 26 2009 8:17AM Matching: tarceva. • Mission bottle to help cancer victim. Hawkes Bay Today: Oct 24 2009 8:35AM Matching: tarceva ...
http://www.bioportfolio.com/biocorporate/30779-TARCEVA.pdf...

BioPortfolio - BioPortfolio - TARCEVA
BioPortfolio - TARCEVA - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/30779/www.t...

BioPortfolio - OSI Pharmaceuticals - Profile
Behind Tarceva, we have an emerging oncology pipeline of molecular ... Our Flagship Product Tarceva (erlotinib) is a small molecule ...
http://www.bioportfolio.com/biocorporate/7940-OSI%2525252525...

BioPortfolio - OSI Pharmaceuticals - Profile
OSI Pharma (OSI) and Roch Announce Tarceva Net Sales; ATLAS Data Sweep ... UPDATE 1-OSI Pharma posts higher Tarceva global sales in Q3 ...
http://www.bioportfolio.com/biocorporate/7940-OSI%2525252525...

Protein Kinase Inhibitors in Oncology: Drug Pipeline Update 2008
Protein kinase inhibitors such as Gleevec, Iressa and Tarceva have allowed the biotechnology industry to deliver on the promise of targeted cancer drugs. ...
http://www.bioportfolio.com/cgi-bin/acatalog/Protein_Kinase_...

Results from other life science and pharmaceutical sites:

Genentech: Medicines: Tarceva
Tarceva is a selective and orally active inhibitor of the Epidermal Growth Factor Receptor (EGFR), tyrosine kinase, that is associated with the aberrant
...
http://www.gene.com/gene/products/information/oncology/tarce...

Erlotinib - Wikipedia, the free encyclopedia
In November 2008 a study undertaken by Roche Holding of Switzerland claimed that Tarceva given immediately ...
http://en.wikipedia.org/wiki/Erlotinib...

Genentech: Pipeline: Tarceva
Skip to Content for Tarceva Menu for Tarceva About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu Careers Menu ...
http://www.gene.com/gene/pipeline/status/oncology/tarceva/...

FINAL 30April 2009 PI-Clean
TARCEVA safely and effectively. See full prescribing information for .... showed no clinical benefit with the concurrent administration of TARCEVA with ...
http://www.osip.com/full_PI_tarceva...

Genentech: Medicines: Tarceva Fact Sheet
Skip to Content for Tarceva Fact Sheet Menu for Tarceva Fact Sheet About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu ...
http://www.gene.com/gene/products/information/oncology/tarce...

Tarceva (erlotinib) Tablets NDA 21-743, S003 Supplemental NDA ...
Tarceva (erlotinib) is an orally-available human epidermal growth factor receptor .... Tarceva (erlotinib) received full approval in the US by the FDA on
18 ...
http://www.fda.gov/ohrms/dockets/AC/05/briefing/2005-4174B1_...

Genentech: Investors: Tarceva - Historical Sales
Skip to Content for Tarceva - Historical Sales Menu for Tarceva - Historical Sales About Us Menu Research Menu Development Menu Medicines Menu Investors ...
http://www.gene.com/gene/ir/financials/historical/tarceva.ht...

Tarceva® (erlotinib) tablets
Tarceva® (erlotinib) is a small molecule human epidermal growth factor type 1/ epidermal growth factor receptor (HER1/EGFR) inhibitor which is currently ...
http://www.osip.com/tarceva...

ACS :: Tarceva Approved for Lung Cancer
19 Nov 2004 ... Patients with the most common type of lung cancer now have another treatment option: erlotinib (marketed as Tarceva).
http://www.cancer.org/docroot/NWS/content/NWS_1_1x_Tarceva_A...

The current situation: erlotinib (Tarceva) and gefitinib (Iressa ...
The current situation: erlotinib (Tarceva) and gefitinib (Iressa) in non-small cell lung cancer. Comis RL. Drexel University College of Medicine, ...
http://www.ncbi.nlm.nih.gov/pubmed/16079313...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.